Syncope, Vasovagal Clinical Trial
Official title:
Impact of Blood Phobia on Fainting Susceptibility
The primary purpose of this study is to characterize cardiovascular autonomic function to emotional stimuli (blood-injection-injury phobia [needle phobia]) during an orthostatic (upright) challenge in individuals with and without known needle phobia. It is well established that emotional stress can produce hypotensive (low blood pressure) reactions. Interestingly, these hypotensive reactions to venipuncture (even with minimal blood drawn), insulin injections, finger sticks for blood sugar monitoring, dental care, and vaccinations can affect up to a quarter of adults and appear to be uniquely associated with blood-injection-injury phobia rather than other phobias. These hypotensive reactions can ultimately lead to a vasovagal syncope (fainting) response, and lead to increased avoidance of medical and dental procedures as a result of this phobia. Ultimately, this has severe implications on public health and places additional strain on the Canadian healthcare system. Currently, there is limited understanding surrounding the initiation of this response. Additionally, a comprehensive profile of cardiovascular autonomic function during exposure to provoking stimuli during orthostatic stress has not been captured in the literature. We will test individuals with and without blood-injection-injury phobia using our standard approach while exposing them to emotional stimuli.
The purpose of this study is to characterize cardiovascular autonomic function to emotional stimuli (blood-injection-injury phobia [needle phobia]) during an orthostatic (upright) challenge in individuals with and without known needle phobia. It is well established that emotional stress can produce hypotensive (low blood pressure) reactions. Interestingly, these hypotensive reactions to venipuncture (even with minimal blood drawn), insulin injections, finger sticks for blood sugar monitoring, dental care, and vaccinations can affect up to a quarter of adults and appear to be uniquely associated with blood-injection-injury phobia rather than other phobias. These hypotensive reactions can ultimately lead to a vasovagal syncope (fainting) response, and lead to increased avoidance of medical and dental procedures as a result of this phobia. Ultimately, this has severe implications on public health and places additional strain on the Canadian healthcare system. Currently, there is limited understanding surrounding the initiation of this response. Additionally, a comprehensive profile of cardiovascular autonomic function during exposure to provoking stimuli during orthostatic stress has not been captured in the literature. We will test individuals with and without blood-injection-injury phobia using our standard approach while exposing them to emotional stimuli. Volunteers (n=20) will be asked to undergo a "tilt test" to assess cardiovascular reflex control and orthostatic tolerance (measured as time to presyncope, or near fainting, in minutes). We and others have previously shown this technique to be reproducible, reliable, and to have high sensitivity and specificity for differentiating persons with differing orthostatic tolerance, or for examining the effects of interventions aimed at improving orthostatic tolerance. Volunteers will undergo the test on two separate days. On one test day (the order of which will be randomized) the volunteer will be shown a series of photos and videos during the upright tilt portion of the test. One day the series of content will consist of blood-injection-injury phobia content and the other day will have neutral content. Cardiovascular measures will be monitored through the test. The study will be conducted in a randomised fashion. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05555771 -
Paediatric Syncope in the Emergency Department
|
N/A | |
| Completed |
NCT06038708 -
Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
|
||
| Recruiting |
NCT03159156 -
Respiration and Applied Tension Strategies to Reduce Vasovagal Reactions to Blood Donation
|
N/A | |
| Not yet recruiting |
NCT05572034 -
Cardiac Autonomic Denervation for Cardio-inhibitory Syncope
|
N/A | |
| Completed |
NCT05729724 -
Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
|
||
| Recruiting |
NCT04595942 -
Midodrine and Fludrocortisone for Vasovagal Syncope
|
Phase 3 | |
| Completed |
NCT03903744 -
Cardioneuroablation for Reflex Syncope
|
N/A | |
| Completed |
NCT05782647 -
Wearable Monitor in Patients With Syncope
|
N/A | |
| Completed |
NCT00465439 -
Safety/Efficacy Study of Local Anesthetic Prior to Femoral Artery Sheath Removal
|
N/A | |
| Active, not recruiting |
NCT01621464 -
Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study)
|
Phase 4 | |
| Recruiting |
NCT06458140 -
Cardioneuroablation and Ventricular Proarrhythmia
|
N/A | |
| Recruiting |
NCT06440291 -
Cardioneuroablation for Reflex Syncope and Exercise Capacity
|
N/A | |
| Completed |
NCT01617616 -
Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
|
N/A | |
| Recruiting |
NCT05086679 -
Compression Stockings for Treating Vasovagal Syncope Trial
|
N/A | |
| Completed |
NCT04772755 -
Presyncope (Syncope) Prevention Study
|
N/A | |
| Completed |
NCT03533829 -
Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study
|
N/A | |
| Completed |
NCT05782699 -
Detecting Syncope by an Integrated Multisensor Patch-type Recorder
|
N/A | |
| Completed |
NCT01695525 -
Influence of Yoga in Patients With Neurocardiogenic Syncope
|
Phase 0 | |
| Completed |
NCT00475462 -
The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents
|
N/A | |
| Completed |
NCT04972123 -
The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope
|
Phase 2 |